AZ, Merck get FDA okay for Lynparza as adjuvant breast cancer therapy - - Pharmaphorum

Retrieved on: 2022-03-14 02:54:15

Tags for this article:

Click the tags to see associated articles and topics

AZ, Merck get FDA okay for Lynparza as adjuvant breast cancer therapy - - Pharmaphorum. View article details on hiswai:

Excerpt

FDA approves AstraZeneca and Merck's Lynparza as adjuvant/neoadjuvant therapy for high-risk, BRCA+, HER2- breast cancer, keeping it a step ahead ...

Article found on: pharmaphorum.com